Browsing by Subject "Neoplasias mamárias"
Now showing items 1-10 of 12
-
Acurácia diagnóstica da biópsia percutânea com agulha grossa orientada por estereotaxia nas lesões mamárias categoria BI-RADS® 4
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2007-12-01)PURPOSE: to assess the accuracy (rate of correct predictions) of stereotactic core needle biopsy (CNB) of risk category BI-RADS® 4 breast lesions. METHODS: a retrospective analysis of category BI-RADS® 4 breast lesions ...
-
Adesão de mulheres mastectomizadas ao início precoce de um programa de reabilitação
(Escola Paulista de Enfermagem, Universidade Federal de São Paulo (UNIFESP), 2007-09-01)OBJECTIVES: The main objective was to measure adherence to an early rehabilitation program among women who underwent mastectomy. Other specific objectives included the identification of women's difficulties to comply with ...
-
Associação entre os polimorfismos HaeIII e MspI do gene para o receptor alfa de estrogênio e densidade mamográfica em mulheres após a menopausa
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2006-10-01)PURPOSE: To assess the presence of estrogen receptor gene polymorphisms HaeIII and MspI as well as clinical factors, and their possible associations with high mammographic density in post-menopausal women. METHODS: One ...
-
Associação entre polimorfismos do gene do receptor alfa de estrogênio com a densidade mamográfica em mulheres após a menopausa
(Universidade Federal de São Paulo (UNIFESP), 2009-04-29)Introduction: Genes that encode proteins involved at biosynthesis, action and metabolism of sexual steroids are polymorphics. This condition could explain individual variations in mammographic density. The objectives of ...
-
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem
(Conselho Brasileiro de Oftalmologia, 2004-08-01)PURPOSE: Tamoxifen, an antiestrogen, has been used as an effective therapeutic agent in the treatment of breast cancer. The drug has been shown to cause ocular toxic effects. The purpose of this study was to determine ...
-
Estimativa de custo do rastreamento mamográfico em mulheres no climatério
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2005-07-01)PURPOSE: to evaluate the cost of preventive mammographic screening in climacteric women, as compared to the cost of breast cancer treatment in more advanced stages. METHODS: one thousand and fourteen patients attended at ...
-
Estudo da Imunorreação do Anticorpo Monoclonal Ki-67 (MIB-1) e dos Receptores de Estrogênio e Progesterona no Carcinoma de Mama de Mulheres Tratadas com Tamoxifeno em Baixa Dosagem
(Universidade Federal de São Paulo (UNIFESP), 2006-12-31)Breast carcinoma is the most common malignancy among women, and it has a major impact on mortality. Studies of primary chemoprevention with tamoxifen have generated high expectations and considerable success rates. The ...
-
Múltiplos fibroadenomas bilaterais após transplante renal e imunossupressão com ciclosporina A
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2007-07-01)Fibroadenoma is the most frequent benign neoplasia in the female breast and it is considered a mixed tumor, constituted by variable amounts of connective and epithelial tissue. Cyclosporine A seems to be related with the ...
-
A pesquisa do linfonodo sentinela para o câncer de mama na prática clínica do ginecologista brasileiro
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2007-03-01)Axillary nodal metastasis is still the most important breast cancer prognostic factor. As in approximately 80% of the patients with tumors measuring less than 2 cm the axillary lymph nodes are negative, it has been proposed ...
-
Polimorfismo do gene do receptor de progesterona (PROGINS) em mulheres com câncer de mama: estudo caso-controle
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2005-08-01)PURPOSE: to analyze the correlation between PROGINS polymorphism and breast cancer. METHODS: a case-control study was carried out from April to October 2004. The genotypes of 50 women with breast cancer and 49 healthy women ...